

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 6.84507492 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 6.84507492 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 5.24534918 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.24534918 |
| 5 | COPII vesicle coating (GO:0048208) | 5.18043078 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.91458451 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 4.91458451 |
| 8 | endocrine pancreas development (GO:0031018) | 4.85688624 |
| 9 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.78591205 |
| 10 | intestinal absorption (GO:0050892) | 4.60413847 |
| 11 | intestinal cholesterol absorption (GO:0030299) | 4.57861123 |
| 12 | peptide hormone processing (GO:0016486) | 4.46175869 |
| 13 | aromatic amino acid family catabolic process (GO:0009074) | 4.35100411 |
| 14 | protein retention in ER lumen (GO:0006621) | 4.34389026 |
| 15 | cellular glucuronidation (GO:0052695) | 4.20857627 |
| 16 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.11044942 |
| 17 | glucocorticoid biosynthetic process (GO:0006704) | 4.04831161 |
| 18 | glucuronate metabolic process (GO:0019585) | 4.01061915 |
| 19 | uronic acid metabolic process (GO:0006063) | 4.01061915 |
| 20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.95468759 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 3.93108017 |
| 22 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.83088697 |
| 23 | macroautophagy (GO:0016236) | 3.81717433 |
| 24 | drug transmembrane transport (GO:0006855) | 3.81499167 |
| 25 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.79898516 |
| 26 | signal peptide processing (GO:0006465) | 3.70741607 |
| 27 | regulation of extracellular matrix disassembly (GO:0010715) | 3.70657392 |
| 28 | regulation of cholesterol homeostasis (GO:2000188) | 3.66982511 |
| 29 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.66336714 |
| 30 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.65699584 |
| 31 | drug catabolic process (GO:0042737) | 3.65489801 |
| 32 | cysteine metabolic process (GO:0006534) | 3.64967965 |
| 33 | high-density lipoprotein particle remodeling (GO:0034375) | 3.63143530 |
| 34 | tryptophan metabolic process (GO:0006568) | 3.58792597 |
| 35 | acylglycerol homeostasis (GO:0055090) | 3.58780421 |
| 36 | triglyceride homeostasis (GO:0070328) | 3.58780421 |
| 37 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.58570545 |
| 38 | glyoxylate metabolic process (GO:0046487) | 3.58001907 |
| 39 | homocysteine metabolic process (GO:0050667) | 3.55046606 |
| 40 | indole-containing compound catabolic process (GO:0042436) | 3.54471879 |
| 41 | indolalkylamine catabolic process (GO:0046218) | 3.54471879 |
| 42 | tryptophan catabolic process (GO:0006569) | 3.54471879 |
| 43 | C21-steroid hormone biosynthetic process (GO:0006700) | 3.53850966 |
| 44 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.51132293 |
| 45 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.50255472 |
| 46 | alpha-linolenic acid metabolic process (GO:0036109) | 3.48070819 |
| 47 | lysine metabolic process (GO:0006553) | 3.45704126 |
| 48 | lysine catabolic process (GO:0006554) | 3.45704126 |
| 49 | Leydig cell differentiation (GO:0033327) | 3.44119474 |
| 50 | hormone catabolic process (GO:0042447) | 3.43192790 |
| 51 | glandular epithelial cell differentiation (GO:0002067) | 3.43169763 |
| 52 | positive regulation of glycolytic process (GO:0045821) | 3.41954627 |
| 53 | reverse cholesterol transport (GO:0043691) | 3.39870355 |
| 54 | phospholipid efflux (GO:0033700) | 3.39484733 |
| 55 | exocrine pancreas development (GO:0031017) | 3.37977803 |
| 56 | tyrosine metabolic process (GO:0006570) | 3.35299299 |
| 57 | protein carboxylation (GO:0018214) | 3.34129177 |
| 58 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.34129177 |
| 59 | regulation of cholesterol esterification (GO:0010872) | 3.33435985 |
| 60 | 4-hydroxyproline metabolic process (GO:0019471) | 3.33328545 |
| 61 | vesicle coating (GO:0006901) | 3.32381354 |
| 62 | bile acid and bile salt transport (GO:0015721) | 3.32242538 |
| 63 | bile acid biosynthetic process (GO:0006699) | 3.30140708 |
| 64 | positive regulation of nuclease activity (GO:0032075) | 3.29423069 |
| 65 | urea cycle (GO:0000050) | 3.28341574 |
| 66 | urea metabolic process (GO:0019627) | 3.28341574 |
| 67 | protein maturation by protein folding (GO:0022417) | 3.27525082 |
| 68 | flavonoid metabolic process (GO:0009812) | 3.27471075 |
| 69 | kynurenine metabolic process (GO:0070189) | 3.27453447 |
| 70 | bile acid metabolic process (GO:0008206) | 3.27421342 |
| 71 | negative regulation of complement activation (GO:0045916) | 3.24518003 |
| 72 | androgen biosynthetic process (GO:0006702) | 3.18851719 |
| 73 | glucocorticoid metabolic process (GO:0008211) | 3.18591378 |
| 74 | aromatic amino acid family metabolic process (GO:0009072) | 3.18033208 |
| 75 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.17907461 |
| 76 | lipoprotein metabolic process (GO:0042157) | 3.17061467 |
| 77 | cell adhesion mediated by integrin (GO:0033627) | 3.14660665 |
| 78 | drug transport (GO:0015893) | 3.14466941 |
| 79 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.12121760 |
| 80 | plasma lipoprotein particle remodeling (GO:0034369) | 3.11635045 |
| 81 | protein-lipid complex remodeling (GO:0034368) | 3.11635045 |
| 82 | macromolecular complex remodeling (GO:0034367) | 3.11635045 |
| 83 | type B pancreatic cell development (GO:0003323) | 3.09830263 |
| 84 | regulation of bile acid biosynthetic process (GO:0070857) | 3.09613576 |
| 85 | adhesion of symbiont to host (GO:0044406) | 3.08450253 |
| 86 | toxin metabolic process (GO:0009404) | 3.06634130 |
| 87 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.06132343 |
| 88 | sphingomyelin metabolic process (GO:0006684) | 3.05123433 |
| 89 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.04694689 |
| 90 | negative regulation of protein activation cascade (GO:2000258) | 3.04166542 |
| 91 | sequestering of metal ion (GO:0051238) | 3.03314744 |
| 92 | cholesterol efflux (GO:0033344) | 3.02918632 |
| 93 | nitrogen cycle metabolic process (GO:0071941) | 3.02865279 |
| 94 | tricarboxylic acid metabolic process (GO:0072350) | 3.01974928 |
| 95 | cellular modified amino acid catabolic process (GO:0042219) | 3.00690183 |
| 96 | drug metabolic process (GO:0017144) | 2.99181058 |
| 97 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.98535193 |
| 98 | cellular response to unfolded protein (GO:0034620) | 2.98280019 |
| 99 | benzene-containing compound metabolic process (GO:0042537) | 2.98080584 |
| 100 | negative regulation of sterol transport (GO:0032372) | 2.97811634 |
| 101 | negative regulation of cholesterol transport (GO:0032375) | 2.97811634 |
| 102 | progesterone metabolic process (GO:0042448) | 2.97202950 |
| 103 | regulation of nuclease activity (GO:0032069) | 2.96581007 |
| 104 | cellular ketone body metabolic process (GO:0046950) | 2.96247789 |
| 105 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.95676430 |
| 106 | skin morphogenesis (GO:0043589) | 2.95192683 |
| 107 | indolalkylamine metabolic process (GO:0006586) | 2.94025601 |
| 108 | amino-acid betaine metabolic process (GO:0006577) | 2.93666224 |
| 109 | negative regulation of hormone metabolic process (GO:0032351) | 2.93481270 |
| 110 | virion attachment to host cell (GO:0019062) | 2.93201100 |
| 111 | adhesion of symbiont to host cell (GO:0044650) | 2.93201100 |
| 112 | short-chain fatty acid metabolic process (GO:0046459) | 2.93178199 |
| 113 | regulation of triglyceride catabolic process (GO:0010896) | 2.92487483 |
| 114 | cellular response to vitamin D (GO:0071305) | 2.92155330 |
| 115 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.91383776 |
| 116 | ER-nucleus signaling pathway (GO:0006984) | 2.91128895 |
| 117 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.89824743 |
| 118 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.89768605 |
| 119 | fatty acid beta-oxidation (GO:0006635) | 2.87366321 |
| 120 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.86979683 |
| 121 | xenobiotic catabolic process (GO:0042178) | 2.86330847 |
| 122 | fatty acid oxidation (GO:0019395) | 2.85881920 |
| 123 | cellular response to topologically incorrect protein (GO:0035967) | 2.84116107 |
| 124 | glandular epithelial cell development (GO:0002068) | 2.83022887 |
| 125 | urate metabolic process (GO:0046415) | 2.82651109 |
| 126 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.79986212 |
| 127 | epoxygenase P450 pathway (GO:0019373) | 2.75717974 |
| 128 | auditory receptor cell differentiation (GO:0042491) | 2.74105175 |
| 129 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.69322645 |
| 130 | cellular response to vitamin (GO:0071295) | 2.67858711 |
| 131 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.67095865 |
| 132 | keratan sulfate catabolic process (GO:0042340) | 2.64457055 |
| 133 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.63821378 |
| 134 | angiotensin maturation (GO:0002003) | 2.60119752 |
| 135 | positive regulation of calcium ion import (GO:0090280) | 2.58511240 |
| 136 | desmosome organization (GO:0002934) | 2.56696517 |
| 137 | regulation of fibrinolysis (GO:0051917) | 2.54286899 |
| 138 | cellular response to cadmium ion (GO:0071276) | 2.53306899 |
| 139 | positive regulation of actin filament depolymerization (GO:0030836) | 2.51246942 |
| 140 | response to follicle-stimulating hormone (GO:0032354) | 2.50609238 |
| 141 | extracellular regulation of signal transduction (GO:1900115) | 2.49005781 |
| 142 | extracellular negative regulation of signal transduction (GO:1900116) | 2.49005781 |
| 143 | vitamin D metabolic process (GO:0042359) | 2.47487714 |
| 144 | type B pancreatic cell proliferation (GO:0044342) | 2.46090283 |
| 145 | chondrocyte proliferation (GO:0035988) | 2.44289660 |
| 146 | glomerular basement membrane development (GO:0032836) | 2.43883807 |
| 147 | transcytosis (GO:0045056) | 2.43424651 |
| 148 | collagen fibril organization (GO:0030199) | 2.42885093 |
| 149 | cellular response to antibiotic (GO:0071236) | 2.41663065 |
| 150 | insulin secretion (GO:0030073) | 2.40663710 |
| 151 | wound healing, spreading of epidermal cells (GO:0035313) | 2.39975467 |
| 152 | positive regulation of protein autophosphorylation (GO:0031954) | 2.39657201 |
| 153 | sphingolipid catabolic process (GO:0030149) | 2.39464790 |
| 154 | oligosaccharide catabolic process (GO:0009313) | 2.39167940 |
| 155 | cellular zinc ion homeostasis (GO:0006882) | 2.37431891 |
| 156 | positive regulation of macroautophagy (GO:0016239) | 2.33053699 |
| 157 | androgen metabolic process (GO:0008209) | 2.32941756 |
| 158 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.32923064 |
| 159 | membrane lipid catabolic process (GO:0046466) | 2.30874380 |
| 160 | C21-steroid hormone metabolic process (GO:0008207) | 2.30695036 |
| 161 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.30286423 |
| 162 | ethanol oxidation (GO:0006069) | 2.28624724 |
| 163 | smooth muscle tissue development (GO:0048745) | 2.28308396 |
| 164 | phenylpropanoid metabolic process (GO:0009698) | 2.28001281 |
| 165 | nitric oxide biosynthetic process (GO:0006809) | 2.27760730 |
| 166 | omega-hydroxylase P450 pathway (GO:0097267) | 2.25739080 |
| 167 | epithelial cell fate commitment (GO:0072148) | 2.24639245 |
| 168 | regulation of plasminogen activation (GO:0010755) | 2.20279097 |
| 169 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.20069883 |
| 170 | regulation of metalloenzyme activity (GO:0048552) | 2.19390868 |
| 171 | positive regulation of hormone metabolic process (GO:0032352) | 2.18808005 |
| 172 | positive regulation of steroid metabolic process (GO:0045940) | 2.18454544 |
| 173 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.17819370 |
| 174 | negative regulation of humoral immune response (GO:0002921) | 2.17731616 |
| 175 | cellular response to gonadotropin stimulus (GO:0071371) | 2.16223857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.69911209 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.10514186 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.13181146 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.10468857 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.15274483 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.84640744 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.67461792 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 3.62944148 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.32764702 |
| 10 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.19585815 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.82645437 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.61256481 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.47024490 |
| 14 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.44230678 |
| 15 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.35731989 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.98847429 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.96080876 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95639526 |
| 19 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.93726437 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.89125164 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.88966648 |
| 22 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.82832929 |
| 23 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.81289036 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.77677876 |
| 25 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.77545115 |
| 26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71173400 |
| 27 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.71028571 |
| 28 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.62530744 |
| 29 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.60457637 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53764515 |
| 31 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.51585738 |
| 32 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.51056961 |
| 33 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.50301651 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.48196471 |
| 35 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.47498053 |
| 36 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.44533698 |
| 37 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.43403212 |
| 38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.41285290 |
| 39 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.37370139 |
| 40 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.37287463 |
| 41 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.34821626 |
| 42 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.30261792 |
| 43 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.29342343 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.27492784 |
| 45 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27275786 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25177765 |
| 47 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.21933076 |
| 48 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.21294575 |
| 49 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.20507311 |
| 50 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19942976 |
| 51 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19832129 |
| 52 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.17927999 |
| 53 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.17927999 |
| 54 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.17033133 |
| 55 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.15911283 |
| 56 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.14217555 |
| 57 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.14217555 |
| 58 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13905118 |
| 59 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.13360505 |
| 60 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12405287 |
| 61 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09873819 |
| 62 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.09504784 |
| 63 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.08437295 |
| 64 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.07054600 |
| 65 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.06304702 |
| 66 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.05909719 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03863481 |
| 68 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.03464696 |
| 69 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.00557231 |
| 70 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00471926 |
| 71 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.99455151 |
| 72 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99398235 |
| 73 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.98709200 |
| 74 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.97984823 |
| 75 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95543405 |
| 76 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94560688 |
| 77 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.94557453 |
| 78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93973292 |
| 79 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.93919958 |
| 80 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93758861 |
| 81 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92343511 |
| 82 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.92326942 |
| 83 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92165793 |
| 84 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.90946819 |
| 85 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89552690 |
| 86 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89433876 |
| 87 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.88748852 |
| 88 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.88319510 |
| 89 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87655921 |
| 90 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.87519208 |
| 91 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.87456410 |
| 92 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.86307857 |
| 93 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.86259575 |
| 94 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.86213780 |
| 95 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.86012544 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85403314 |
| 97 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.84975538 |
| 98 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.84950201 |
| 99 | AR_20517297_ChIP-Seq_VCAP_Human | 0.84729896 |
| 100 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84528048 |
| 101 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.83743098 |
| 102 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.81577293 |
| 103 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81306796 |
| 104 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.81190879 |
| 105 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.79958449 |
| 106 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.78219666 |
| 107 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.77681496 |
| 108 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.76796870 |
| 109 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.75151574 |
| 110 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.74563591 |
| 111 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.74563591 |
| 112 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.73931269 |
| 113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.71073968 |
| 114 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69464380 |
| 115 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.69343880 |
| 116 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.68848631 |
| 117 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.68380781 |
| 118 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.68245247 |
| 119 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.68190571 |
| 120 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.67174771 |
| 121 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66877947 |
| 122 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.66835482 |
| 123 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.66448504 |
| 124 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.65241967 |
| 125 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64712143 |
| 126 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.63437017 |
| 127 | CJUN_26792858_Chip-Seq_BT549_Human | 0.63228267 |
| 128 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62730026 |
| 129 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.61262722 |
| 130 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.59522715 |
| 131 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.57603955 |
| 132 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.57448700 |
| 133 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.56107776 |
| 134 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.55140886 |
| 135 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.54492071 |
| 136 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.52567184 |
| 137 | RXR_22108803_ChIP-Seq_LS180_Human | 0.52345493 |
| 138 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.52221315 |
| 139 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.52083704 |
| 140 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.51878286 |
| 141 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.51583719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.94150057 |
| 2 | MP0005360_urolithiasis | 5.63828392 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 5.19534627 |
| 4 | MP0005365_abnormal_bile_salt | 4.53218156 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 4.25582299 |
| 6 | MP0003195_calcinosis | 3.90154627 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.76606757 |
| 8 | MP0004043_abnormal_pH_regulation | 3.59882396 |
| 9 | MP0003252_abnormal_bile_duct | 3.58666377 |
| 10 | MP0003283_abnormal_digestive_organ | 3.47481437 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 3.09796973 |
| 12 | MP0010352_gastrointestinal_tract_polyps | 3.07486789 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.93106736 |
| 14 | MP0004272_abnormal_basement_membrane | 2.87425272 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.48891354 |
| 16 | MP0003279_aneurysm | 2.47501886 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.46664973 |
| 18 | MP0002909_abnormal_adrenal_gland | 2.46127845 |
| 19 | MP0002693_abnormal_pancreas_physiology | 2.44941388 |
| 20 | MP0009840_abnormal_foam_cell | 2.39522254 |
| 21 | MP0010368_abnormal_lymphatic_system | 2.38755764 |
| 22 | MP0001944_abnormal_pancreas_morphology | 2.30676002 |
| 23 | MP0005275_abnormal_skin_tensile | 2.28481711 |
| 24 | MP0004264_abnormal_extraembryonic_tissu | 2.18432654 |
| 25 | MP0003183_abnormal_peptide_metabolism | 2.17680459 |
| 26 | MP0005503_abnormal_tendon_morphology | 2.16995299 |
| 27 | MP0005220_abnormal_exocrine_pancreas | 2.16179859 |
| 28 | MP0001958_emphysema | 2.14627124 |
| 29 | MP0005332_abnormal_amino_acid | 2.13255424 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 2.09677314 |
| 31 | MP0009643_abnormal_urine_homeostasis | 2.05552465 |
| 32 | MP0000678_abnormal_parathyroid_gland | 1.98512907 |
| 33 | MP0003868_abnormal_feces_composition | 1.96880742 |
| 34 | MP0005379_endocrine/exocrine_gland_phen | 1.92579962 |
| 35 | MP0002295_abnormal_pulmonary_circulatio | 1.85546532 |
| 36 | MP0002078_abnormal_glucose_homeostasis | 1.78696087 |
| 37 | MP0010386_abnormal_urinary_bladder | 1.78654118 |
| 38 | MP0004019_abnormal_vitamin_homeostasis | 1.77241109 |
| 39 | MP0002118_abnormal_lipid_homeostasis | 1.74783798 |
| 40 | MP0003566_abnormal_cell_adhesion | 1.69276497 |
| 41 | MP0001542_abnormal_bone_strength | 1.62891642 |
| 42 | MP0000609_abnormal_liver_physiology | 1.60765194 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.58510862 |
| 44 | MP0005083_abnormal_biliary_tract | 1.57672108 |
| 45 | MP0002896_abnormal_bone_mineralization | 1.49261021 |
| 46 | MP0000013_abnormal_adipose_tissue | 1.46479316 |
| 47 | MP0001765_abnormal_ion_homeostasis | 1.41394995 |
| 48 | MP0005636_abnormal_mineral_homeostasis | 1.39634352 |
| 49 | MP0003941_abnormal_skin_development | 1.38461987 |
| 50 | MP0001756_abnormal_urination | 1.36199327 |
| 51 | MP0003091_abnormal_cell_migration | 1.35411511 |
| 52 | * MP0009780_abnormal_chondrocyte_physiolo | 1.34850695 |
| 53 | MP0002876_abnormal_thyroid_physiology | 1.34787069 |
| 54 | MP0005319_abnormal_enzyme/_coenzyme | 1.33570556 |
| 55 | MP0003950_abnormal_plasma_membrane | 1.33152091 |
| 56 | MP0005023_abnormal_wound_healing | 1.30874731 |
| 57 | MP0008004_abnormal_stomach_pH | 1.29029690 |
| 58 | MP0002928_abnormal_bile_duct | 1.27842334 |
| 59 | MP0002837_dystrophic_cardiac_calcinosis | 1.25465927 |
| 60 | MP0003191_abnormal_cellular_cholesterol | 1.22594585 |
| 61 | MP0002060_abnormal_skin_morphology | 1.20898224 |
| 62 | MP0001243_abnormal_dermal_layer | 1.18048529 |
| 63 | MP0005595_abnormal_vascular_smooth | 1.13729929 |
| 64 | MP0001764_abnormal_homeostasis | 1.13398927 |
| 65 | MP0003953_abnormal_hormone_level | 1.13074024 |
| 66 | MP0005058_abnormal_lysosome_morphology | 1.08469800 |
| 67 | MP0005646_abnormal_pituitary_gland | 1.07105590 |
| 68 | MP0010234_abnormal_vibrissa_follicle | 1.04532816 |
| 69 | MP0000538_abnormal_urinary_bladder | 1.01879777 |
| 70 | MP0001270_distended_abdomen | 0.98857471 |
| 71 | MP0000613_abnormal_salivary_gland | 0.98520576 |
| 72 | MP0000767_abnormal_smooth_muscle | 0.98415385 |
| 73 | MP0005535_abnormal_body_temperature | 0.96376921 |
| 74 | MP0005164_abnormal_response_to | 0.95803807 |
| 75 | * MP0009642_abnormal_blood_homeostasis | 0.93374175 |
| 76 | MP0003045_fibrosis | 0.92312304 |
| 77 | MP0001879_abnormal_lymphatic_vessel | 0.92160535 |
| 78 | MP0005623_abnormal_meninges_morphology | 0.89722044 |
| 79 | MP0005408_hypopigmentation | 0.89601716 |
| 80 | MP0003879_abnormal_hair_cell | 0.88504363 |
| 81 | MP0005448_abnormal_energy_balance | 0.87986759 |
| 82 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.87890269 |
| 83 | MP0003186_abnormal_redox_activity | 0.87576162 |
| 84 | MP0008961_abnormal_basal_metabolism | 0.83557930 |
| 85 | MP0005670_abnormal_white_adipose | 0.83312702 |
| 86 | MP0005508_abnormal_skeleton_morphology | 0.83032019 |
| 87 | MP0004510_myositis | 0.82753728 |
| 88 | MP0000230_abnormal_systemic_arterial | 0.82292249 |
| 89 | * MP0000163_abnormal_cartilage_morphology | 0.81885547 |
| 90 | MP0005165_increased_susceptibility_to | 0.81815880 |
| 91 | MP0005084_abnormal_gallbladder_morpholo | 0.81671106 |
| 92 | MP0005334_abnormal_fat_pad | 0.79525875 |
| 93 | MP0005310_abnormal_salivary_gland | 0.79426807 |
| 94 | MP0000516_abnormal_urinary_system | 0.78450851 |
| 95 | MP0005367_renal/urinary_system_phenotyp | 0.78450851 |
| 96 | * MP0000462_abnormal_digestive_system | 0.77558126 |
| 97 | MP0000598_abnormal_liver_morphology | 0.77060850 |
| 98 | MP0009697_abnormal_copulation | 0.76745186 |
| 99 | MP0006082_CNS_inflammation | 0.74371447 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.71180073 |
| 101 | MP0003172_abnormal_lysosome_physiology | 0.70459755 |
| 102 | MP0002998_abnormal_bone_remodeling | 0.69126244 |
| 103 | MP0000003_abnormal_adipose_tissue | 0.67672376 |
| 104 | MP0003866_abnormal_defecation | 0.64663367 |
| 105 | MP0003075_altered_response_to | 0.63906358 |
| 106 | MP0005248_abnormal_Harderian_gland | 0.61901979 |
| 107 | MP0003705_abnormal_hypodermis_morpholog | 0.60494562 |
| 108 | MP0005166_decreased_susceptibility_to | 0.60460399 |
| 109 | MP0001661_extended_life_span | 0.58925364 |
| 110 | MP0001501_abnormal_sleep_pattern | 0.58441864 |
| 111 | MP0000639_abnormal_adrenal_gland | 0.57855285 |
| 112 | MP0002971_abnormal_brown_adipose | 0.55539195 |
| 113 | MP0002234_abnormal_pharynx_morphology | 0.55182712 |
| 114 | MP0008469_abnormal_protein_level | 0.54967227 |
| 115 | * MP0003795_abnormal_bone_structure | 0.54755460 |
| 116 | MP0004085_abnormal_heartbeat | 0.54459878 |
| 117 | MP0005187_abnormal_penis_morphology | 0.54173083 |
| 118 | MP0002168_other_aberrant_phenotype | 0.54017052 |
| 119 | MP0009672_abnormal_birth_weight | 0.54007150 |
| 120 | * MP0002115_abnormal_skeleton_extremities | 0.53557000 |
| 121 | MP0002254_reproductive_system_inflammat | 0.53500540 |
| 122 | MP0005257_abnormal_intraocular_pressure | 0.51131797 |
| 123 | MP0003959_abnormal_lean_body | 0.50668965 |
| 124 | MP0009384_cardiac_valve_regurgitation | 0.50540382 |
| 125 | MP0000681_abnormal_thyroid_gland | 0.48981176 |
| 126 | * MP0005381_digestive/alimentary_phenotyp | 0.48651873 |
| 127 | MP0004134_abnormal_chest_morphology | 0.48586915 |
| 128 | MP0005376_homeostasis/metabolism_phenot | 0.48203731 |
| 129 | MP0003656_abnormal_erythrocyte_physiolo | 0.47239166 |
| 130 | MP0002098_abnormal_vibrissa_morphology | 0.46924044 |
| 131 | MP0001664_abnormal_digestion | 0.46875150 |
| 132 | MP0004782_abnormal_surfactant_physiolog | 0.46321000 |
| 133 | MP0005266_abnormal_metabolism | 0.45378801 |
| 134 | MP0009765_abnormal_xenobiotic_induced | 0.44434294 |
| 135 | MP0005375_adipose_tissue_phenotype | 0.43365805 |
| 136 | MP0006054_spinal_hemorrhage | 0.43234934 |
| 137 | MP0002163_abnormal_gland_morphology | 0.42612849 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 6.00642420 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 5.75914676 |
| 3 | Hypoglycemic seizures (HP:0002173) | 5.70152829 |
| 4 | Premature rupture of membranes (HP:0001788) | 5.27450405 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.06765531 |
| 6 | Symptomatic seizures (HP:0011145) | 5.05656232 |
| 7 | Ketoacidosis (HP:0001993) | 4.48317734 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 4.43583704 |
| 9 | Abnormal tarsal ossification (HP:0008369) | 4.21132384 |
| 10 | Conjugated hyperbilirubinemia (HP:0002908) | 4.11884444 |
| 11 | Protrusio acetabuli (HP:0003179) | 4.11205356 |
| 12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.92342616 |
| 13 | Hyperglycemia (HP:0003074) | 3.89131954 |
| 14 | Cardiovascular calcification (HP:0011915) | 3.80214422 |
| 15 | Ketosis (HP:0001946) | 3.76408511 |
| 16 | Xanthomatosis (HP:0000991) | 3.76177616 |
| 17 | Generalized aminoaciduria (HP:0002909) | 3.64846964 |
| 18 | Epiphyseal dysplasia (HP:0002656) | 3.62801174 |
| 19 | Abnormality of the intrinsic pathway (HP:0010989) | 3.55119312 |
| 20 | Mitral stenosis (HP:0001718) | 3.53105110 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.49479425 |
| 22 | Hypobetalipoproteinemia (HP:0003563) | 3.45825337 |
| 23 | Late onset (HP:0003584) | 3.43376334 |
| 24 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.38706054 |
| 25 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.37493821 |
| 26 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.37493821 |
| 27 | Vascular calcification (HP:0004934) | 3.36731976 |
| 28 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.36521949 |
| 29 | Prolonged partial thromboplastin time (HP:0003645) | 3.34132124 |
| 30 | Protuberant abdomen (HP:0001538) | 3.28807160 |
| 31 | Abnormal foot bone ossification (HP:0010675) | 3.21738441 |
| 32 | Abnormality of the common coagulation pathway (HP:0010990) | 3.19283989 |
| 33 | Cupped ribs (HP:0000887) | 3.17225122 |
| 34 | Fat malabsorption (HP:0002630) | 3.09176419 |
| 35 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.06015574 |
| 36 | Deep venous thrombosis (HP:0002625) | 3.04510096 |
| 37 | Aortic dissection (HP:0002647) | 3.04504608 |
| 38 | Flat acetabular roof (HP:0003180) | 2.98589482 |
| 39 | Abnormality of purine metabolism (HP:0004352) | 2.95223691 |
| 40 | Hyperglycinuria (HP:0003108) | 2.88010390 |
| 41 | Aortic aneurysm (HP:0004942) | 2.86849956 |
| 42 | Abdominal distention (HP:0003270) | 2.85628111 |
| 43 | Enlarged penis (HP:0000040) | 2.84278301 |
| 44 | Abnormal pancreas size (HP:0012094) | 2.83178443 |
| 45 | Malnutrition (HP:0004395) | 2.80227233 |
| 46 | Gout (HP:0001997) | 2.79561846 |
| 47 | Delayed epiphyseal ossification (HP:0002663) | 2.73698492 |
| 48 | Hyperactive renin-angiotensin system (HP:0000841) | 2.71401341 |
| 49 | Vascular tortuosity (HP:0004948) | 2.69494213 |
| 50 | Cervical subluxation (HP:0003308) | 2.68875057 |
| 51 | Abnormality of dentin (HP:0010299) | 2.66794887 |
| 52 | Metaphyseal irregularity (HP:0003025) | 2.66350158 |
| 53 | Abnormality of proline metabolism (HP:0010907) | 2.63070802 |
| 54 | Hydroxyprolinuria (HP:0003080) | 2.63070802 |
| 55 | Epidermoid cyst (HP:0200040) | 2.59902968 |
| 56 | Hypolipoproteinemia (HP:0010981) | 2.55623208 |
| 57 | Hypoplastic ischia (HP:0003175) | 2.54208144 |
| 58 | Wormian bones (HP:0002645) | 2.52955107 |
| 59 | Hematochezia (HP:0002573) | 2.51382127 |
| 60 | Increased CSF protein (HP:0002922) | 2.49582564 |
| 61 | Insulin resistance (HP:0000855) | 2.48342917 |
| 62 | Soft skin (HP:0000977) | 2.47052630 |
| 63 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.46564382 |
| 64 | Vacuolated lymphocytes (HP:0001922) | 2.46459896 |
| 65 | Abnormality of vitamin metabolism (HP:0100508) | 2.43885924 |
| 66 | Vitreoretinal degeneration (HP:0000655) | 2.43230842 |
| 67 | Abnormality of the ischium (HP:0003174) | 2.42400405 |
| 68 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.41918501 |
| 69 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.41918501 |
| 70 | Abnormality of glycolipid metabolism (HP:0010969) | 2.41918501 |
| 71 | Irregular epiphyses (HP:0010582) | 2.40775730 |
| 72 | Flat capital femoral epiphysis (HP:0003370) | 2.40043473 |
| 73 | Abnormality of urine glucose concentration (HP:0011016) | 2.39209169 |
| 74 | Glycosuria (HP:0003076) | 2.39209169 |
| 75 | Decreased circulating renin level (HP:0003351) | 2.39001371 |
| 76 | Abnormality of glycine metabolism (HP:0010895) | 2.38959907 |
| 77 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.38959907 |
| 78 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.37938802 |
| 79 | Metaphyseal cupping (HP:0003021) | 2.35336942 |
| 80 | Abnormality of nucleobase metabolism (HP:0010932) | 2.35313383 |
| 81 | Broad metatarsal (HP:0001783) | 2.35144308 |
| 82 | Hyperammonemia (HP:0001987) | 2.34836617 |
| 83 | Nuclear cataract (HP:0100018) | 2.34563840 |
| 84 | Hyperphosphatemia (HP:0002905) | 2.34404351 |
| 85 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.33869227 |
| 86 | Hyperbilirubinemia (HP:0002904) | 2.32817670 |
| 87 | Skin nodule (HP:0200036) | 2.29745898 |
| 88 | Follicular hyperkeratosis (HP:0007502) | 2.28947927 |
| 89 | Osteomalacia (HP:0002749) | 2.28927678 |
| 90 | Fragile skin (HP:0001030) | 2.28038945 |
| 91 | Abnormality of vitamin B metabolism (HP:0004340) | 2.27292451 |
| 92 | * Mucopolysacchariduria (HP:0008155) | 2.26480557 |
| 93 | * Urinary glycosaminoglycan excretion (HP:0003541) | 2.26480557 |
| 94 | Arterial tortuosity (HP:0005116) | 2.25692491 |
| 95 | * Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.24793312 |
| 96 | * Abnormality of polysaccharide metabolism (HP:0011012) | 2.24793312 |
| 97 | * Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.24793312 |
| 98 | Dysostosis multiplex (HP:0000943) | 2.24583900 |
| 99 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.24153868 |
| 100 | Hypokalemia (HP:0002900) | 2.23772848 |
| 101 | Joint hemorrhage (HP:0005261) | 2.23274532 |
| 102 | Striae distensae (HP:0001065) | 2.23125047 |
| 103 | Large for gestational age (HP:0001520) | 2.22784271 |
| 104 | Hyperglycinemia (HP:0002154) | 2.22439421 |
| 105 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.22407229 |
| 106 | Vertebral compression fractures (HP:0002953) | 2.22074494 |
| 107 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.21059994 |
| 108 | Osteolytic defects of the hand bones (HP:0009699) | 2.20846445 |
| 109 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.20846445 |
| 110 | Genu recurvatum (HP:0002816) | 2.20563692 |
| 111 | Alkalosis (HP:0001948) | 2.19673232 |
| 112 | Testicular neoplasm (HP:0010788) | 2.17912350 |
| 113 | Enlarged epiphyses (HP:0010580) | 2.16861822 |
| 114 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.16792633 |
| 115 | Ovoid vertebral bodies (HP:0003300) | 2.15761316 |
| 116 | Elevated alkaline phosphatase (HP:0003155) | 2.15375070 |
| 117 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.15130832 |
| 118 | Hyperlipoproteinemia (HP:0010980) | 2.14302834 |
| 119 | Hypophosphatemia (HP:0002148) | 2.14039467 |
| 120 | Abnormal sex determination (HP:0012244) | 2.13534141 |
| 121 | Sex reversal (HP:0012245) | 2.13534141 |
| 122 | Hyperphosphaturia (HP:0003109) | 2.12738105 |
| 123 | Ankle contracture (HP:0006466) | 2.12442455 |
| 124 | Abnormality of chloride homeostasis (HP:0011422) | 2.11632926 |
| 125 | Spinal rigidity (HP:0003306) | 2.10785440 |
| 126 | Steatorrhea (HP:0002570) | 2.10660873 |
| 127 | Long toe (HP:0010511) | 2.10623184 |
| 128 | Beaking of vertebral bodies (HP:0004568) | 2.08523195 |
| 129 | Irritability (HP:0000737) | 2.06795597 |
| 130 | Hypoalphalipoproteinemia (HP:0003233) | 2.06657583 |
| 131 | Small epiphyses (HP:0010585) | 2.06219400 |
| 132 | Abnormality of renin-angiotensin system (HP:0000847) | 2.06111989 |
| 133 | Abnormality of carpal bone ossification (HP:0006257) | 2.05941758 |
| 134 | Enlarged kidneys (HP:0000105) | 2.05919011 |
| 135 | Proximal tubulopathy (HP:0000114) | 2.05831183 |
| 136 | Abnormality of complement system (HP:0005339) | 2.03841354 |
| 137 | Hyperextensible skin (HP:0000974) | 2.03576936 |
| 138 | Peritonitis (HP:0002586) | 2.01184741 |
| 139 | Atrophic scars (HP:0001075) | 2.00480562 |
| 140 | Metabolic acidosis (HP:0001942) | 2.00411662 |
| 141 | Progressive neurologic deterioration (HP:0002344) | 1.99603062 |
| 142 | Tetraparesis (HP:0002273) | 1.99274534 |
| 143 | Congenital glaucoma (HP:0001087) | 1.98440577 |
| 144 | Congenital sensorineural hearing impairment (HP:0008527) | 1.96032733 |
| 145 | Abnormal cartilage morphology (HP:0002763) | 1.95393832 |
| 146 | Abnormal delivery (HP:0001787) | 1.94107023 |
| 147 | Cardiomegaly (HP:0001640) | 1.93639604 |
| 148 | Thin bony cortex (HP:0002753) | 1.93104810 |
| 149 | Dilatation of the ascending aorta (HP:0005111) | 1.92286167 |
| 150 | Bladder diverticulum (HP:0000015) | 1.92015326 |
| 151 | Widely patent fontanelles and sutures (HP:0004492) | 1.91736146 |
| 152 | J-shaped sella turcica (HP:0002680) | 1.91572646 |
| 153 | Renal salt wasting (HP:0000127) | 1.90698430 |
| 154 | Genu varum (HP:0002970) | 1.90429000 |
| 155 | Acanthocytosis (HP:0001927) | 1.90413451 |
| 156 | Overgrowth (HP:0001548) | 1.89927848 |
| 157 | Hypothermia (HP:0002045) | 1.89558653 |
| 158 | Complement deficiency (HP:0004431) | 1.89390359 |
| 159 | Hypokalemic alkalosis (HP:0001949) | 1.88831500 |
| 160 | Limb hypertonia (HP:0002509) | 1.87138442 |
| 161 | Pancreatitis (HP:0001733) | 1.86550590 |
| 162 | Osteoarthritis (HP:0002758) | 1.85733635 |
| 163 | Neonatal short-limb short stature (HP:0008921) | 1.85151929 |
| 164 | Flattened epiphyses (HP:0003071) | 1.85096448 |
| 165 | Spondylolisthesis (HP:0003302) | 1.84551729 |
| 166 | Unilateral renal agenesis (HP:0000122) | 1.83962198 |
| 167 | Blue sclerae (HP:0000592) | 1.83710856 |
| 168 | Hyperaldosteronism (HP:0000859) | 1.82528998 |
| 169 | Aneurysm (HP:0002617) | 1.82366888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 6.66450039 |
| 2 | FRK | 4.21572785 |
| 3 | PASK | 4.12364622 |
| 4 | MYLK | 3.71986928 |
| 5 | TAOK3 | 3.68590792 |
| 6 | ERN1 | 3.46768912 |
| 7 | MAPK15 | 3.08161334 |
| 8 | TRPM7 | 2.75613035 |
| 9 | BCKDK | 2.55933389 |
| 10 | MAP3K2 | 2.53435286 |
| 11 | SIK1 | 2.46242873 |
| 12 | FLT3 | 2.38284698 |
| 13 | MAP3K3 | 2.32667183 |
| 14 | MAP3K12 | 2.11710199 |
| 15 | PRKD3 | 2.11489589 |
| 16 | HIPK2 | 2.03982540 |
| 17 | LATS1 | 2.01613695 |
| 18 | ACVR1B | 2.00870600 |
| 19 | LIMK1 | 2.00806202 |
| 20 | WNK4 | 1.86032423 |
| 21 | MST1R | 1.82573152 |
| 22 | MET | 1.68469814 |
| 23 | PTK6 | 1.64857030 |
| 24 | TRIB3 | 1.58060799 |
| 25 | FGFR4 | 1.52282764 |
| 26 | FGFR2 | 1.46396606 |
| 27 | STK38L | 1.45352430 |
| 28 | TGFBR2 | 1.42478433 |
| 29 | NUAK1 | 1.36657430 |
| 30 | GRK1 | 1.32207829 |
| 31 | WNK3 | 1.31796483 |
| 32 | IRAK3 | 1.30424041 |
| 33 | AKT3 | 1.29196068 |
| 34 | PTK2 | 1.28697629 |
| 35 | MAPKAPK3 | 1.27750899 |
| 36 | DAPK2 | 1.24705108 |
| 37 | EPHA3 | 1.19508605 |
| 38 | ADRBK2 | 1.17490068 |
| 39 | TIE1 | 1.17190891 |
| 40 | PDGFRA | 1.13840652 |
| 41 | MAP3K1 | 1.12618916 |
| 42 | MAP2K6 | 1.11217182 |
| 43 | PRKG2 | 1.08956014 |
| 44 | PAK4 | 1.08096061 |
| 45 | MAP2K2 | 1.05125073 |
| 46 | NTRK1 | 1.04388515 |
| 47 | EIF2AK3 | 1.02885751 |
| 48 | PHKG2 | 1.02621245 |
| 49 | PHKG1 | 1.02621245 |
| 50 | TTN | 1.01864716 |
| 51 | STK38 | 1.01588958 |
| 52 | EPHB2 | 0.97862438 |
| 53 | STK24 | 0.96127588 |
| 54 | DDR2 | 0.96125552 |
| 55 | DYRK1B | 0.95706238 |
| 56 | PAK2 | 0.94358294 |
| 57 | PTK2B | 0.89452493 |
| 58 | ABL2 | 0.89277713 |
| 59 | ERBB4 | 0.85548761 |
| 60 | ROCK1 | 0.85156390 |
| 61 | RIPK1 | 0.84032164 |
| 62 | MST4 | 0.83339114 |
| 63 | PIK3CG | 0.83322322 |
| 64 | SCYL2 | 0.82516296 |
| 65 | JAK1 | 0.80573934 |
| 66 | FER | 0.79497568 |
| 67 | LMTK2 | 0.79240938 |
| 68 | JAK2 | 0.78970347 |
| 69 | CAMKK2 | 0.77164440 |
| 70 | PAK3 | 0.76315363 |
| 71 | TAOK1 | 0.73855408 |
| 72 | PRKAA1 | 0.73242793 |
| 73 | ADRBK1 | 0.72913679 |
| 74 | CDC42BPA | 0.72648839 |
| 75 | PRKCH | 0.71065789 |
| 76 | IRAK1 | 0.69413718 |
| 77 | PIK3CA | 0.69229748 |
| 78 | MAP3K10 | 0.68332220 |
| 79 | ROCK2 | 0.66047470 |
| 80 | GSK3A | 0.65880925 |
| 81 | FGFR3 | 0.65073389 |
| 82 | PKN2 | 0.64105522 |
| 83 | EPHB1 | 0.62775583 |
| 84 | DAPK3 | 0.61773760 |
| 85 | NLK | 0.61697440 |
| 86 | SGK3 | 0.61380663 |
| 87 | EPHA2 | 0.60126178 |
| 88 | SGK2 | 0.58771576 |
| 89 | PRKAA2 | 0.57926807 |
| 90 | MAP3K9 | 0.56815102 |
| 91 | ERBB3 | 0.55977272 |
| 92 | LATS2 | 0.55216785 |
| 93 | OXSR1 | 0.53656886 |
| 94 | PRKACG | 0.53568161 |
| 95 | MAP3K14 | 0.53267937 |
| 96 | JAK3 | 0.52032121 |
| 97 | CAMK1G | 0.51524817 |
| 98 | PRKD2 | 0.51170925 |
| 99 | ZAP70 | 0.50143109 |
| 100 | YES1 | 0.50104342 |
| 101 | ITK | 0.48890124 |
| 102 | PRKCE | 0.48657183 |
| 103 | MAPK11 | 0.48374294 |
| 104 | ILK | 0.46746362 |
| 105 | GRK7 | 0.46674916 |
| 106 | PRKCI | 0.46557238 |
| 107 | SGK494 | 0.45678719 |
| 108 | SGK223 | 0.45678719 |
| 109 | TYK2 | 0.45495113 |
| 110 | CHUK | 0.45261137 |
| 111 | IGF1R | 0.44733155 |
| 112 | RET | 0.44517843 |
| 113 | TBK1 | 0.41753763 |
| 114 | MELK | 0.40194687 |
| 115 | PDPK1 | 0.39442151 |
| 116 | MAP2K1 | 0.39307866 |
| 117 | CAMK2G | 0.38871244 |
| 118 | BRSK2 | 0.37843524 |
| 119 | STK3 | 0.36668882 |
| 120 | NEK6 | 0.33946471 |
| 121 | NTRK3 | 0.33701505 |
| 122 | STK39 | 0.33316003 |
| 123 | PINK1 | 0.33049720 |
| 124 | CSK | 0.31291477 |
| 125 | BMPR2 | 0.30790663 |
| 126 | AKT2 | 0.30677399 |
| 127 | NME1 | 0.30278239 |
| 128 | RPS6KB1 | 0.29789294 |
| 129 | TEC | 0.29558893 |
| 130 | CSNK1A1 | 0.29281153 |
| 131 | CAMK1D | 0.29079679 |
| 132 | MTOR | 0.29066945 |
| 133 | NEK9 | 0.27723136 |
| 134 | PRKD1 | 0.27038868 |
| 135 | PRKCA | 0.25861008 |
| 136 | TESK1 | 0.25529592 |
| 137 | ERBB2 | 0.24836835 |
| 138 | CAMK2D | 0.22314609 |
| 139 | PRKCZ | 0.21490571 |
| 140 | PRKACA | 0.21158545 |
| 141 | PDGFRB | 0.20495603 |
| 142 | RPS6KA2 | 0.18249802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.88051085 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.13302714 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.62343505 |
| 4 | * Sulfur metabolism_Homo sapiens_hsa00920 | 2.61587209 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.58428441 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.56552288 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.52465311 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.50673527 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.23866752 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.21470170 |
| 11 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.06680286 |
| 12 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.04717840 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.01089470 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.87814604 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.86705641 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 1.75377681 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.75003629 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.73701601 |
| 19 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.70006898 |
| 20 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.67441830 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.60236579 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.59384513 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.55018772 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.49980916 |
| 25 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.44263115 |
| 26 | ABC transporters_Homo sapiens_hsa02010 | 1.41499902 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.41230610 |
| 28 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.40748313 |
| 29 | * Selenocompound metabolism_Homo sapiens_hsa00450 | 1.40363064 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.39854925 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.39807813 |
| 32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.39232530 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.34191506 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.34127777 |
| 35 | Galactose metabolism_Homo sapiens_hsa00052 | 1.31262785 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.31169010 |
| 37 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.30944303 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.29736457 |
| 39 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.27874320 |
| 40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.26345774 |
| 41 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.24396842 |
| 42 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.21340647 |
| 43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.16801323 |
| 44 | Insulin secretion_Homo sapiens_hsa04911 | 1.15982298 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.14211294 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.13965612 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.10205150 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.06833715 |
| 49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.06728127 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.06391837 |
| 51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.05897436 |
| 52 | Retinol metabolism_Homo sapiens_hsa00830 | 1.04645703 |
| 53 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.02784165 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.97447773 |
| 55 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.93452547 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90199831 |
| 57 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.89857319 |
| 58 | Focal adhesion_Homo sapiens_hsa04510 | 0.88890310 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.87930481 |
| 60 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.85541853 |
| 61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.84494769 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.84150116 |
| 63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.83770522 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.80716328 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.80403946 |
| 66 | Pertussis_Homo sapiens_hsa05133 | 0.79377100 |
| 67 | Renin secretion_Homo sapiens_hsa04924 | 0.79124737 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78866471 |
| 69 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.78553209 |
| 70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.78499706 |
| 71 | Mineral absorption_Homo sapiens_hsa04978 | 0.75776207 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75127891 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74772789 |
| 74 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.73918180 |
| 75 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.73157521 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71182776 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.70200989 |
| 78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66867953 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66342777 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64932395 |
| 81 | Lysosome_Homo sapiens_hsa04142 | 0.63398827 |
| 82 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.63080657 |
| 83 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62360710 |
| 84 | Tight junction_Homo sapiens_hsa04530 | 0.62323918 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61685846 |
| 86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60782641 |
| 87 | Carbon metabolism_Homo sapiens_hsa01200 | 0.58143367 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57952597 |
| 89 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.56819194 |
| 90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54757699 |
| 91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54407577 |
| 92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54371598 |
| 93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54239262 |
| 94 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53708145 |
| 95 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48651987 |
| 96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47525106 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.46684609 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46409712 |
| 99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46312553 |
| 100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.45926349 |
| 101 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43998028 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41391511 |
| 103 | Sulfur relay system_Homo sapiens_hsa04122 | 0.41292833 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40871164 |
| 105 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.39896075 |
| 106 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.38700719 |
| 107 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38305516 |
| 108 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37876439 |
| 109 | Cocaine addiction_Homo sapiens_hsa05030 | 0.36019569 |
| 110 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35883989 |
| 111 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35681756 |
| 112 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.35312264 |
| 113 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32885948 |
| 114 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.32292438 |
| 115 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.32091337 |
| 116 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.29558735 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.24446298 |
| 118 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22718412 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22422180 |
| 120 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.21802266 |
| 121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20054251 |
| 122 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.20050443 |
| 123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.16117950 |
| 124 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.15663367 |
| 125 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.15344035 |
| 126 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.14303870 |

